Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Expression of Glypican 3 is an Independent Prognostic Biomarker in Primary Gastro-Esophageal Adenocarcinoma and Corresponding Serum Exosomes.

Rahbari M, Pecqueux M, Aust D, Stephan H, Tiebel O, Chatzigeorgiou A, Tonn T, Baenke F, Rao V, Ziegler N, Greif H, Lin K, Weitz J, Rahbari NN, Kahlert C.

J Clin Med. 2019 May 16;8(5). pii: E696. doi: 10.3390/jcm8050696.

2.

Evidence-based quality standards improve prognosis in colon cancer care.

Trautmann F, Reißfelder C, Pecqueux M, Weitz J, Schmitt J.

Eur J Surg Oncol. 2018 Sep;44(9):1324-1330. doi: 10.1016/j.ejso.2018.05.013. Epub 2018 May 17.

PMID:
29885983
3.

Inhibition of Six1 affects tumour invasion and the expression of cancer stem cell markers in pancreatic cancer.

Lerbs T, Bisht S, Schölch S, Pecqueux M, Kristiansen G, Schneider M, Hofmann BT, Welsch T, Reissfelder C, Rahbari NN, Fritzmann J, Brossart P, Weitz J, Feldmann G, Kahlert C.

BMC Cancer. 2017 Apr 7;17(1):249. doi: 10.1186/s12885-017-3225-5.

4.

A Comprehensive MicroRNA Expression Profile of Liver and Lung Metastases of Colorectal Cancer with Their Corresponding Host Tissue and Its Prognostic Impact on Survival.

Pecqueux M, Liebetrau I, Werft W, Dienemann H, Muley T, Pfannschmidt J, Müssle B, Rahbari N, Schölch S, Büchler MW, Weitz J, Reissfelder C, Kahlert C.

Int J Mol Sci. 2016 Oct 21;17(10). pii: E1755.

5.

Free intraperitoneal tumor cells and outcome in gastric cancer patients: a systematic review and meta-analysis.

Pecqueux M, Fritzmann J, Adamu M, Thorlund K, Kahlert C, Reißfelder C, Weitz J, Rahbari NN.

Oncotarget. 2015 Nov 3;6(34):35564-78. doi: 10.18632/oncotarget.5595. Review.

6.

Overexpression of SIX1 is an independent prognostic marker in stage I-III colorectal cancer.

Kahlert C, Lerbs T, Pecqueux M, Herpel E, Hoffmeister M, Jansen L, Brenner H, Chang-Claude J, Bläker H, Kloor M, Roth W, Pilarsky C, Rahbari NN, Schölch S, Bork U, Reissfelder C, Weitz J, Aust D, Koch M.

Int J Cancer. 2015 Nov 1;137(9):2104-13. doi: 10.1002/ijc.29596. Epub 2015 May 21.

7.

Prognostic impact of a compartment-specific angiogenic marker profile in patients with pancreatic cancer.

Kahlert C, Fiala M, Musso G, Halama N, Keim S, Mazzone M, Lasitschka F, Pecqueux M, Klupp F, Schmidt T, Rahbari N, Schölch S, Pilarsky C, Ulrich A, Schneider M, Weitz J, Koch M.

Oncotarget. 2014 Dec 30;5(24):12978-89.

Supplemental Content

Loading ...
Support Center